InvestorsHub Logo

ziploc_1

02/02/24 12:06 PM

#421105 RE: Tatsumaki #421102

Tats...I don't believe that Amarin would apply for 9 new patents on a drug that has already been patented by Mochida, a company, whom they have a partnership agreement with...and who have already patented MND-2119 by themselves

"Based on 9 U.S. Provision PATENT APPLICATIONS, Amarin has secured a worldwide patent PRIORITY claim to a lymph-releasing composition of eicosapentaenoic acid ethyl ester (LR-EtEPA) technology/invention and methods of using the same to increase EPA uptake in tissues to treat and/or prevent the onset of a number of diseases."